Literature DB >> 27202417

Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients.

B Ehlken1, J Driedger2, L Hofmann-Xu1, G Paulus2, K Berger1, C de Moor3, C Schroeder1, J Clune4, J Tyczynski5.   

Abstract

Entities:  

Year:  2014        PMID： 27202417     DOI： 10.1016/j.jval.2014.08.2439

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.

Authors:  Paweł Knapp; Lubomir Bodnar; Agnieszka Błachnio-Zabielska; Joanna Reszeć; Magdalena Świderska; Adrian Chabowski
Journal:  Arch Med Sci       Date:  2018-07-10       Impact factor: 3.318
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.